218 related articles for article (PubMed ID: 11850621)
1. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways.
Falck J; Petrini JH; Williams BR; Lukas J; Bartek J
Nat Genet; 2002 Mar; 30(3):290-4. PubMed ID: 11850621
[TBL] [Abstract][Full Text] [Related]
2. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
3. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
4. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest.
Girard PM; Riballo E; Begg AC; Waugh A; Jeggo PA
Oncogene; 2002 Jun; 21(27):4191-9. PubMed ID: 12082606
[TBL] [Abstract][Full Text] [Related]
5. Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.
Goldstone S; Pavey S; Forrest A; Sinnamon J; Gabrielli B
Oncogene; 2001 Feb; 20(8):921-32. PubMed ID: 11314027
[TBL] [Abstract][Full Text] [Related]
6. The mismatch repair system is required for S-phase checkpoint activation.
Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R
Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371
[TBL] [Abstract][Full Text] [Related]
7. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Lim DS; Kim ST; Xu B; Maser RS; Lin J; Petrini JH; Kastan MB
Nature; 2000 Apr; 404(6778):613-7. PubMed ID: 10766245
[TBL] [Abstract][Full Text] [Related]
8. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation.
Horejsí Z; Falck J; Bakkenist CJ; Kastan MB; Lukas J; Bartek J
Oncogene; 2004 Apr; 23(17):3122-7. PubMed ID: 15048089
[TBL] [Abstract][Full Text] [Related]
9. MDC1 is required for the intra-S-phase DNA damage checkpoint.
Goldberg M; Stucki M; Falck J; D'Amours D; Rahman D; Pappin D; Bartek J; Jackson SP
Nature; 2003 Feb; 421(6926):952-6. PubMed ID: 12607003
[TBL] [Abstract][Full Text] [Related]
10. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
11. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.
Yazdi PT; Wang Y; Zhao S; Patel N; Lee EY; Qin J
Genes Dev; 2002 Mar; 16(5):571-82. PubMed ID: 11877377
[TBL] [Abstract][Full Text] [Related]
12. Intra-S-phase checkpoint activation by direct CDK2 inhibition.
Zhu Y; Alvarez C; Doll R; Kurata H; Schebye XM; Parry D; Lees E
Mol Cell Biol; 2004 Jul; 24(14):6268-77. PubMed ID: 15226429
[TBL] [Abstract][Full Text] [Related]
13. Chk2 activation dependence on Nbs1 after DNA damage.
Buscemi G; Savio C; Zannini L; Miccichè F; Masnada D; Nakanishi M; Tauchi H; Komatsu K; Mizutani S; Khanna K; Chen P; Concannon P; Chessa L; Delia D
Mol Cell Biol; 2001 Aug; 21(15):5214-22. PubMed ID: 11438675
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of S-phase progression triggered by UVA-induced ROS does not require a functional DNA damage checkpoint response in mammalian cells.
Girard PM; Pozzebon M; Delacôte F; Douki T; Smirnova V; Sage E
DNA Repair (Amst); 2008 Sep; 7(9):1500-16. PubMed ID: 18603484
[TBL] [Abstract][Full Text] [Related]
15. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
16. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
17. Role of cell cycle in mediating sensitivity to radiotherapy.
Pawlik TM; Keyomarsi K
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):928-42. PubMed ID: 15234026
[TBL] [Abstract][Full Text] [Related]
18. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
Jin J; Ang XL; Ye X; Livingstone M; Harper JW
J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine.
Sampath D; Shi Z; Plunkett W
Mol Pharmacol; 2002 Sep; 62(3):680-8. PubMed ID: 12181445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
